Overview

Perforomist Versus Foradil Evaluated by Inspiratory Capacity and High Resolution Computed Tomography (HRCT)

Status:
Withdrawn
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effects of nebulized formoterol fumarate (Perforomist) to dry-powder inhaler formoterol fumarate (Foradil). Perforomist is a solution that is made into very fine spray (using a nebulizer) that is then breathed in over 10-15 minutes. Foradil is taken in a single quick, deep inhalation.
Phase:
Phase 4
Details
Lead Sponsor:
University of California, Los Angeles
Collaborator:
Dey, L.P.
Treatments:
Formoterol Fumarate